TG Therapeutics (TGTX) Insider Trading & Ownership → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free TGTX Stock Alerts $16.42 +0.54 (+3.40%) (As of 05/2/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability TG Therapeutics (NASDAQ:TGTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.20%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$1.01 MNumber OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$4.27 M Get TGTX Insider Trade Alerts Want to know when executives and insiders are buying or selling TG Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TGTX Insider Buying and Selling by Quarter Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. TG Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/12/2024Laurence N CharneyDirectorSell22,000$15.97$351,340.00 1/5/2024Laurence N CharneyDirectorSell17,500$19.03$333,025.00 1/3/2024Sean A PowerCFOSell47,867$16.91$809,430.97 8/11/2023Michael S WeissCEOBuy100,000$10.13$1,013,000.00 6/23/2023Sagar LonialDirectorSell34,854$23.37$814,537.98 6/2/2023Sean A PowerCFOSell73,647$26.70$1,966,374.90 (Data available from 1/1/2013 forward) TGTX Insider Trading Activity - Frequently Asked Questions Who is on TG Therapeutics's Insider Roster? The list of insiders at TG Therapeutics includes Laurence N Charney, Michael S Weiss, Sagar Lonial, Sean A Power, and Yann Echelard. Learn more on insiders at TGTX. What percentage of TG Therapeutics stock is owned by insiders? 9.20% of TG Therapeutics stock is owned by insiders. Learn more on TGTX's insider holdings. Which TG Therapeutics insiders have been buying company stock? The following insiders have purchased TGTX shares in the last 24 months: Michael S Weiss ($1,013,000.00), and Yann Echelard ($95,760.00). How much insider buying is happening at TG Therapeutics? Insiders have purchased a total of 109,000 TGTX shares in the last 24 months for a total of $1,108,760.00 bought. Which TG Therapeutics insiders have been selling company stock? The following insiders have sold TGTX shares in the last 24 months: Laurence N Charney ($1,017,365.00), Sagar Lonial ($814,537.98), and Sean A Power ($2,775,805.87). How much insider selling is happening at TG Therapeutics? Insiders have sold a total of 225,868 TG Therapeutics shares in the last 24 months for a total of $4,607,708.85 sold. More Insider Trading Tools from MarketBeat Related Companies: Dyne Therapeutics Insider Trades Vera Therapeutics Insider Trades Rocket Pharmaceuticals Insider Trades Arvinas Insider Trades Corcept Therapeutics Insider Trades Merus Insider Trades Avidity Biosciences Insider Trades Amphastar Pharmaceuticals Insider Trades Rhythm Pharmaceuticals Insider Trades Keros Therapeutics Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1 This page (NASDAQ:TGTX) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour bank is lying to you.MyBankTrackerThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTrump just won 2024Porter & CompanyHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TG Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.